This company offers genomic data interpretation services to identify optimal cancer therapies based on individual patient sequencing. Their platform analyzes genomic data to provide personalized insights for cancer treatment and risk assessment. By combining data integration, predictive modeling, and visualization, they enable doctors to tailor surveillance and risk-reduction strategies for patients.
Funding
$13M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing complexity and volume of genomic data, combined with the need for personalized cancer therapies, create challenges in identifying optimal treatment strategies for individual patients. Clinicians require efficient and accurate tools to interpret genomic data and translate it into actionable insights for cancer treatment and risk assessment.
Solution
Strand Life Sciences offers comprehensive genomic data interpretation services, providing personalized insights to guide cancer treatment decisions. Their solutions leverage data integration, predictive modeling, and advanced visualization techniques to analyze genomic data from NGS and PCR diagnostics. By harmonizing varied datasets and employing AI-assisted variant interpretation, Strand enables clinicians to tailor surveillance and risk-reduction strategies, ultimately improving patient outcomes. Strand's services include NGS assay validation, variant curation, and the development of custom bioinformatics pipelines.
Target Audience
The primary audience includes clinicians, pharmaceutical companies, biotech firms, and diagnostic companies involved in precision medicine, drug discovery, and oncology research.
Features
- AI-assisted variant interpretation for accurate and efficient analysis
- Real-world data (RWD) integration to derive clinical insights from curated datasets
- Development of custom ontologies and controlled vocabularies for data organization
- Harmonization of diverse data types, including FASTQ, BAM, and CSV files
- Strand Iris software for generating clinical reports from VCF files with AMP-tiered therapy annotations
- Dockerized PacBio workflows for streamlined tool execution and consistent environments
- Expertise in establishing limits of detection, sensitivity, specificity, and reproducibility for NGS assays
- Development of data ingestion pipelines and derived variable generation based on client-specific business rules